[1]
S. R. da R. Decker, L. E. Marzzani, and P. R. de Ferreira, “Extended infusion of cephalosporins, penicillins and carbapenems: a cost-effective point-of-view and critical appraisal of Surviving Sepsis Campaign guidelines”, Evidence, vol. 4, p. e4605, Nov. 2022, doi: 10.17267/2675-021Xevidence.2022.e4605.